TP53 gene
PMV Pharma’s p53 Drug Shows Effect in Ovarian Cancer, but Financial Challenges Loom
PMV Pharmaceuticals; rezatapopt; p53; ovarian cancer; clinical trial; response rate; FDA filing; funding; cash runway
Actionable Insights Powered by AI
PMV Pharmaceuticals; rezatapopt; p53; ovarian cancer; clinical trial; response rate; FDA filing; funding; cash runway